Oxcarbazepine add-on for drug-resistant focal epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oxcarbazepine add-on for drug-resistant focal epilepsy

Published:2020-03-04 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bresnahan Rebecca¹,Atim-Oluk Margaret²,Marson Anthony G¹³⁴

Affiliation:

1. Institute of Translational Medicine, University of Liverpool; Department of Molecular and Clinical Pharmacology; Lower Lane Liverpool UK L9 7LJ

2. South Wales Deanery; Swansea UK

3. The Walton Centre NHS Foundation Trust; Liverpool UK

4. Liverpool Health Partners; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference75 articles.

1. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy;Barcs;Epilepsia,2000

2. Improved seizure control when oxcarbazepine is added to sodium channel blockers or other antiepileptic drugs;D'Souza;Epilepsia,2004

3. Safety and efficacy of oxcarbazepine in refractory epilepsy;Walker;Epilepsia,2000

4. EUCTR2008-003333-25-BG PROSPER www.clinicaltrialsregister.eu/ctr-search/trial/2008-003333-25/BG

5. French JA Baroldi P Brittain ST Johnson JK Abou-Khalil B Brower R Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: A randomized controlled trial. Acta Neurologica Scandinavica 2014 143 53

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New possibilities of overcoming pharmacoresistance in epilepsy;Medical alphabet;2024-01-19

2. REGULATION OF BRAIN NETWORKS BY LEVETIRACETAM AND OXCARBAZEPINE IN CHILDREN WITH BENIGN CHILDHOOD SELF-LIMITED EPILEPSY WITH CENTROTEMPORAL SPIKES (SELECTS);ACTA MEDICA MEDITERR;2023

3. Neurodevelopmental disorders and anti-epileptic treatment in a patient with a SATB1 mutation: A case report;Frontiers in Pediatrics;2022-09-02

4. What are the benefits and harms of supplemental oxcarbazepine for people with drug-resistant focal epilepsy?;Cochrane Clinical Answers;2022-02-15

5. Drugs for patients with epilepsy and excessive daytime sleepiness;Epilepsy & Behavior;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3